Clinical Study
Influence of Age and Neurotoxic HAART Use on Frequency of HIV Sensory Neuropathy
Table 3
Determinants of occurrence of HIV-sensory neuropathy using multivariate regression analysis.
| Variable | | Standard error | value |
| Age (< or ≥40 yrs) | −.566 | .271 | 0.03* | Gender | −.004 | .293 | 0.99 | Height (< or ≥1.7 m) | .627 | .353 | 0.07 | CD4 category (≤ or >200) | .384 | .246 | 0.12 | HAART use | .257 | .389 | 0.50 | HAART type, (stavudine/Non-stavudine-based) | −2.525 | .833 | 0.00* | Duration of HAART use, (< or >12 months) | .666 | .409 | 0.10 |
|
|
*Significantly associated with the presence of HIV-SN.
|